137 related articles for article (PubMed ID: 3334993)
1. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts.
Sands H; Jones PL; Shah SA; Palme D; Vessella RL; Gallagher BM
Cancer Res; 1988 Jan; 48(1):188-93. PubMed ID: 3334993
[TBL] [Abstract][Full Text] [Related]
2. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
Vessella RL; Moon TD; Chiou RK; Nowak JA; Arfman EW; Palme DF; Peterson GA; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6131-9. PubMed ID: 3904980
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.
Kalofonos H; Rowlinson G; Epenetos AA
Cancer Res; 1990 Jan; 50(1):159-63. PubMed ID: 2403414
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunodetection of small human tumor xenografts in spleen of athymic mice by monoclonal antibodies.
Shah SA; Gallagher BM; Sands H
Cancer Res; 1985 Nov; 45(11 Pt 2):5824-9. PubMed ID: 4053053
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.
Steffens MG; Boerman OC; Oyen WJ; Kniest PH; Witjes JA; Oosterhof GO; van Leenders GJ; Debruyne FM; Corstens FH; Oosterwijk E
Cancer Res; 1999 Apr; 59(7):1615-9. PubMed ID: 10197637
[TBL] [Abstract][Full Text] [Related]
7. Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
Stein R; Govindan SV; Mattes MJ; Shih LB; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3079s-3087s. PubMed ID: 10541347
[TBL] [Abstract][Full Text] [Related]
8. Localization of human renal cell carcinoma xenografts with a tumor-preferential monoclonal antibody.
Chiou RK; Vessella RL; Elson MK; Clayman RV; Gonzalez-Campoy JM; Klicka MJ; Shafer RB; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6140-6. PubMed ID: 2415239
[TBL] [Abstract][Full Text] [Related]
9. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
[TBL] [Abstract][Full Text] [Related]
10. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
[TBL] [Abstract][Full Text] [Related]
11. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.
Rowlinson-Busza G; Bamias A; Krausz T; Epenetos AA
Cancer Res; 1991 Jun; 51(12):3251-6. PubMed ID: 2040000
[TBL] [Abstract][Full Text] [Related]
12. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.
LeBerthon B; Khawli LA; Alauddin M; Miller GK; Charak BS; Mazumder A; Epstein AL
Cancer Res; 1991 May; 51(10):2694-8. PubMed ID: 2021947
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts.
Brekken C; Hjelstuen MH; Bruland ØS; de Lange Davies C
Anticancer Res; 2000; 20(5B):3513-9. PubMed ID: 11131655
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
17. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
[TBL] [Abstract][Full Text] [Related]
18. Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody.
Colcher D; Zalutsky M; Kaplan W; Kufe D; Austin F; Schlom J
Cancer Res; 1983 Feb; 43(2):736-42. PubMed ID: 6848189
[TBL] [Abstract][Full Text] [Related]
19. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human tumor antigen expression.
Greiner JW; Hand PH; Colcher D; Weeks M; Thor A; Noguchi P; Pestka S; Schlom J
J Lab Clin Med; 1987 Mar; 109(3):244-61. PubMed ID: 2434589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]